Global Diabetic Neuropathy Market 2014-2018

Price :
Published : May-2014
No. of Pages : 55

Report Description

Avail 20% Discount on this report until 15th January 2015.
For availing the discount please write to us at sales@sandlerresearch.org

Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.

TechNavio’s analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.

Other Prominent Vendors

  • Actavis plc
  • Cephalon Inc.
  • MEDA Pharma GmbH & Co. KG

Key Market Driver

  • Increasing Global Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • High Failure Rate in Clinical Trials.
  • For a full, detailed list, view our report.

Key Market Trend

  • Increasing R&D Activities.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Geographical Segmentation

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors

16. Key Vendor Analysis
16.1 Pfizer Inc.
16.1.1 Business Overview
16.1.2 Key Information
16.1.3 SWOT Analysis
16.2 Eli Lilly and Company
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Janssen Pharmaceuticals Inc.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis

17. Pipeline Analysis
17.1 Phase III Analysis
17.2 Phase II Analysis
17.3 Phase I Analysis
17.4 Discontinued Projects
17.5 Projects on Hold
17.6 Promising Pipeline Molecules
17.6.1 Phase III Promising Pipeline Molecules
17.6.2 Phase II Promising Pipeline Molecules
17.7 Other First-in-class Pipeline Molecules:

18. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global Diabetic Neuropathy Market 2013-2018 (US$ billion)
Exhibit 3: Global Diabetic Neuropathy Market by Geographical Segmentation 2013
Exhibit 4: Eli Lilly and Company: Business Segmentation
Exhibit 5: Diabetic Neuropathy Pipeline Snapshot 2013
Exhibit 6: Discontinued Pipeline Molecules on the basis of MOA

Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Nurse Call System (NCS) Market in the US 2015-2019

Nurse Call System is a communication solution used in healthcare facilities, which enables patients to alert caregivers in case of any routine need or emergency assistance. It serves as the core component of healthcare communication platform and is an innovative, reliable service that alerts the nursing staff through visual and audio signals. It provides the location of the patient in need and indicates the urgency of the call, regardless of the patient's location in the hospital or care center. This not only improves caregiver response time but also creates an environment that is conducive for better patient recovery. The system also allows management and transmission of information within the healthcare facility ensuring continued sustainable care as well as security of patient/resident.......
$2500

Global Male Infertility Market 2015-2019

Infertility is a widespread problem. In male infertility, the male fails to impregnate his female partner after a year of unprotected sex. Male infertility is due to a couple of factors including: Low sperm production Abnormal sperm function or Blockages that prevent the delivery of sperm. Hormonal disturbances to physical problems, or psychological problems can cause male infertility. In most cases, there are no obvious sign or symptoms of an infertility problem. 20 percent of the total infertility is due to male factors. Despite of the scarcity of medicines to treat male infertility, many successful treatment options exist for its many causes. TechNavio's analysts forecast the Global Male Infertility market to grow at a CAGR of 6.60 percent over the period 2014-2019. Cov......
$2500

Global Cystic Fibrosis Market 2015-2019

Cystic fibrosis also known as mucoviscidosis is a genetically-inherited disease. It is one of the most common genetic disorders found in the Caucasian children. The incidence of cystic fibrosis varies among populations, and is substantially less common in Asian and African populations as compared to the people of Caucasoid origin of Europe and North America, with a marked difference within each country. Cystic fibrosis is a chronic disease. The production of a high-salt containing sweat and secretion of abnormal viscous mucus are the major symptoms of cystic fibrosis. TechNavio's analysts forecast the Global Cystic Fibrosis market to grow at a CAGR of 32.50 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects......
$3000

Global Cosmeceuticals Market 2015-2019

Cosmeceuticals are cosmetic products that have medicinal benefits. These products can be purchased over the counter without a doctor's prescription. Cosmeceuticals are discovered as a result of convergence between personal care and pharmaceutical products. TechNavio's analysts forecast the Global Cosmeceuticals market to grow at a CAGR of 8.62 percent over the period 2014-2019. Covered in this Report The Global Cosmeceuticals market can be segmented into six divisions: Skin Care, Hair Care, Injectable, Lip Care, Tooth Whitening, and Others. TechNavio's report, the Global Cosmeceuticals Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA region, Europe, and the APAC region; it also c......
$2500

Global LBS Market in Healthcare Industry 2015-2019

LBS is an information service that uses real-time geographical data from a location-enabled device to provide security services, and information. LBS applications are predominantly used in hospitals to improve efficiency and reduce expenditure. It works on Wi-Fi and RTLS technology in indoor location. LBS is used in hospitals for indoor navigation, tracking staff and patients, location-based messaging, asset management, location analytics, and in integrating with other clinical systems. TechNavio's analysts forecast the Global LBS market in Healthcare Industry to grow at a CAGR of 31.23 percent over the period 2014-2019. Covered in this Report The Global LBS market in Healthcare Industry can be segmented into four segments: Product, Usage, Technology, and Application. TechNavio......
$2500

Global Telehealth Market 2015-2019

Telehealth is a medium of communication between patients and doctors. Telehealth enables doctors to stay in touch with their patients, monitor their health, and provide consultation if need arises. It includes the use of telecommunication technology in providing medical services to patients especially in remote areas. It is very helpful for the patients who earlier had to travel miles to visit doctors for even minor health issues. Today, doctors can monitor the patients with the help of telehealth devices that keep them updated with all their health information and are capable of communicating necessary advices to the patients. TechNavio's analysts forecast the Global Telehealth market to grow at a CAGR of 18.88 percent over the period 2014-2019. Covered in this Report This report......
$2500

Global Active Pharmaceutical Ingredients Market 2015-2019

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis. TechNavio's analysts forecast the Global Active Pharmaceutical Ingredients market to grow at a CAGR of 7.48 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the Global Active Pharmaceutical Ingredients market during the period 2015-2019. To calculate......
$3000

Global Type 2 Diabetes Therapeutics Market 2015-2019

Type 2 diabetes is a chronic condition, which arises due to either the inability of the body to produce enough insulin or insulin resistance, or both. Insulin is a peptide hormone produced by the Islets of Langerhans (pancreatic cells). It is produced in an immature form called preproinsulin, which is proteolytically cleaved to obtain proinsulin and then insulin. Type 2 diabetes nearly accounts for 90-95 percent of the total diabetic cases. Type 2 diabetes is usually diagnosed in middle-aged and older people; however, it can occur even during childhood. Type 2 diabetes was also known as adult-onset diabetes or non-insulin-dependent diabetes. Risk factors for type 2 diabetes include high blood pressure, advancing age, overweight, history of gestational diabetes, family history of diabetes, ......
$3000

Global Pharmaceuticals Wholesale and Distribution Market 2015-2019

The pharmaceutical wholesale and distribution process involves the storage as well as the movement of pharmaceutical products from manufacturing plants to wholesalers, hospitals/clinics, or patients. Pharmaceutical products producers maintain strong partnerships with 3PL providers to encourage efficient and cost-effective metrics. Companies dealing with the distribution of pharmaceutical products comply with strict government regulations, as pharmaceutical products ought to reach patients in usable form so that they may not affect a patient's health. Vigilance at every phase of distribution of pharmaceutical products contributes to their safety record. In some cases, companies might also choose to spur their distribution process through outsourcing, as it is convenient and cost effective. ......
$2500

Osteoporosis Drugs Market in the APAC Region 2015-2019

Osteoporosis is a disease that reduces of the mass and density of bone, and results in increased risk of fracture. In this disease, the risks related to fracture increases because of the increased permeability of the bones. Often, there are no symptoms observed until the first fracture occurs. Increase in age, low body weight, low sex hormones or menopause, and smoking are some of the risk factors associated with this disease. TechNavio's analysts forecast the Osteoporosis Drugs market in APAC to grow at a CAGR of 4.73 percent over the period 2014-2019. Covered in this Report The Osteoporosis Drugs market in APAC can be divided into two segments: Antiresorptives and Anabolics. This report covers the present scenario and the growth prospects of the Osteoporosis Drugs market in APAC......
$2500